GB:XSDR ETF Price & Analysis
XSDR ETF Chart & Stats
18698.00 p
--
Market closed
18698.00 p
--
Day’s Range― - ―
52-Week Range18,008.62 p - 21,154.40 p
Previous Close18,698 p
VolumeN/A
Average Volume (3M)134.00
AUM309.65M
NAV222.18
Expense Ratio0.22%
Holdings Count41
Beta1.01
Inception DateJun 26, 2007
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume41
30 Day Avg. Volume134
AlphaN/A
ETF Overview
dbxt SE600 HC Shs -1C- Capitalisation
The dbxt SE600 HC Shs -1C- Capitalisation ETF, trading under the ticker GB:XSDR, offers investors a unique opportunity to gain exposure to the vibrant and ever-evolving health care sector. As a sector-focused ETF, it zeroes in on the broad-based niche of health care, capturing the dynamism and growth potential inherent in this crucial industry.
Designed for those looking to capitalize on the advancements in medical technology, pharmaceuticals, and health care services, this ETF aggregates a diverse selection of companies at the forefront of innovation and development in the health care field. Its broad-based approach ensures that investors are not only tapping into established health care giants but also emerging leaders poised to make significant impacts.
The dbxt SE600 HC Shs -1C- Capitalisation ETF is ideal for investors seeking to diversify their portfolios with a targeted focus on health care, gaining access to a sector that continues to attract attention due to its essential nature and potential for substantial growth. Whether you are a seasoned investor or new to the world of ETFs, GB:XSDR provides a compelling avenue to harness the power of health care advancements in a single, well-structured financial instrument.
dbxt SE600 HC Shs -1C- Capitalisation (XSDR) Fund Flow Chart
dbxt SE600 HC Shs -1C- Capitalisation (XSDR) 1 year Net Flows: 55M
XSDR ETF News
XSDR ETF FAQ
What was GB:XSDR’s price range in the past 12 months?
GB:XSDR lowest ETF price was 18008.62 p and its highest was 21154.40 p in the past 12 months.
What is the AUM of GB:XSDR?
As of Oct 12, 2026 The AUM of GB:XSDR is 309.65M.
Is GB:XSDR overvalued?
According to Wall Street analysts GB:XSDR’s price is currently Undervalued.
Does GB:XSDR pay dividends?
GB:XSDR does not currently pay dividends.
How many shares outstanding does GB:XSDR have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:XSDR?
Currently, no hedge funds are holding shares in GB:XSDR
Top 10 Holdings
Roche Holding
17.55%
Novartis
15.24%
AstraZeneca plc
13.92%
Novo Nordisk A/S (UK)
7.15%
GlaxoSmithKline plc (UK)
5.48%
Sanofi
5.06%
arGEN X
2.97%
Lonza Group
2.80%
Bayer Ag (UK)
2.79%
Essilorluxottica Sa
2.75%
Total75.71%
See All Holdings







